Related Experiment Video
Updated: Apr 15, 2026
12:18
LINE-1 Methylation Analysis in Mesenchymal Stem Cells Treated with Osteosarcoma-Derived Extracellular Vesicles
Published on: February 1, 2020
6.3K
Antibody microarray profiling of osteosarcoma cell serum for identifying potential biomarkers
Zi-Qiang Zhu1, Jin-Shan Tang2, Duan Gang1
1Department of Orthopedics, The Second Affiliated Hospital of Xuzhou Medical College, Xuzhou, Jiangsu 221006, P.R. China.
Molecular Medicine Reports
|March 28, 2015
Summary
Researchers identified 21 key cytokines in osteosarcoma (OS) patient serum using antibody microarrays. These identified biomarkers show promise for accurate diagnosis and targeted therapy of osteosarcoma.
Area of Science:
- Biochemistry
- Oncology
- Immunology
Background:
- Osteosarcoma (OS) is a primary bone cancer with significant mortality.
- Current diagnostic and therapeutic strategies for OS require improvement.
- Biomarker discovery is crucial for advancing OS management.
Purpose of the Study:
- To identify novel serum biomarkers for osteosarcoma (OS) diagnosis and therapy.
- To utilize antibody microarray profiling for high-throughput cytokine detection.
- To validate potential biomarkers using enzyme-linked immunosorbent assays (ELISAs).
Main Methods:
- Antibody microarray profiling of serum samples from 20 OS patients and 20 healthy controls.
- Statistical analysis to identify significantly differentially expressed cytokines (P<0.05, fold change >2).
- Validation of selected cytokine expression using ELISAs and cluster analysis for classification accuracy.
Main Results:
- Twenty-one cytokines were significantly upregulated in OS serum compared to controls.
- Expression of specific cytokines including IL-6, MCP-1, and TGF-β was confirmed by ELISA.
- Cluster analysis demonstrated 95% accuracy in distinguishing OS serum from control samples based on cytokine profiles.
Conclusions:
- Antibody microarray profiling effectively identified differentially expressed cytokines in osteosarcoma serum.
- Validated cytokines represent potential novel biomarkers for OS diagnosis.
- These biomarkers may contribute to the development of targeted OS therapies.
